Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma

[1] BALLESTER O, 1986, BLOOD S1, V86, pA206

[2] EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) : 1353 - 1356

[3] BOWEN BC, 1995, AM J NEURORADIOL, V16, P61

[4] A PROGRESSIVE PARKINSONIAN-SYNDROME DEVELOPING AFTER CHEMOTHERAPY AND RADIOTHERAPY FOR NON-HODGKINS-LYMPHOMA [J]. MOVEMENT DISORDERS, 1994, 9 (03) : 373 - 375

[5] TREATMENT OF RENAL-FAILURE ASSOCIATED WITH MULTIPLE-MYELOMA - PLASMAPHERESIS, HEMODIALYSIS, AND CHEMOTHERAPY [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) : 863 - 869

[6] LENHARD RE, 1984, CANCER, V53, P1456, DOI 10.1002/1097-0142(19840401)53:7<1456::AID-CNCR2820530705>3.0.CO

[7] 2-C

[8] LITTLEWOOD TJ, 1987, CANCER CHEMOTH PHARM, V19, P180

[9] Luque F A, 1987, Mov Disord, V2, P219, DOI 10.1002/mds.870020309

[10] PETERS W, 1986, J CLIN ONCOL, V4, P645

[1] BALLESTER O, 1986, BLOOD S1, V86, pA206

[2] EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) : 1353 - 1356

[3] BOWEN BC, 1995, AM J NEURORADIOL, V16, P61

[4] A PROGRESSIVE PARKINSONIAN-SYNDROME DEVELOPING AFTER CHEMOTHERAPY AND RADIOTHERAPY FOR NON-HODGKINS-LYMPHOMA [J]. MOVEMENT DISORDERS, 1994, 9 (03) : 373 - 375

[5] TREATMENT OF RENAL-FAILURE ASSOCIATED WITH MULTIPLE-MYELOMA - PLASMAPHERESIS, HEMODIALYSIS, AND CHEMOTHERAPY [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) : 863 - 869

[6] LENHARD RE, 1984, CANCER, V53, P1456, DOI 10.1002/1097-0142(19840401)53:7<1456::AID-CNCR2820530705>3.0.CO

[7] 2-C

[8] LITTLEWOOD TJ, 1987, CANCER CHEMOTH PHARM, V19, P180

[9] Luque F A, 1987, Mov Disord, V2, P219, DOI 10.1002/mds.870020309

[10] PETERS W, 1986, J CLIN ONCOL, V4, P645